Maven Securities LTD Mereo Biopharma Group PLC Transaction History

Maven Securities LTD

  • $346 Million
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.33 - $1.69 $179,671 - $920,134
-544,458 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.04 - $1.7 $238,161 - $389,301
229,001 Added 72.59%
544,458 $610,000
Q4 2021

Feb 14, 2022
BUY
$1.51 - $2.59 $476,340 - $817,033
315,457 New
315,457 $505,000

Others Institutions Holding MREO

# of Institutions
96
Shares Held
99.9M
Call Options Held
2.23M
Put Options Held
179K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $227M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email